Trial Profile
Phase 2 Study of Endostar Combined With CHOP Regimen as the First Line Chemotherapy for Untreated Peripheral T Cell Lymphoma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications T-cell lymphoma
- Focus Therapeutic Use
- 15 Sep 2009 New trial record